| Literature DB >> 27677113 |
Aziz Ari1, Cihad Tatar2, Kenan Buyukasik3, Ozgur Segmen4, Coskun Cakir5, Soykan Arikan6.
Abstract
INTRODUCTION: Cancer developing from more than one origin is called multiple primary cancer (MPC) and is a rare situation. In this article, we report a case presenting to the Emergency Clinic with symptoms of ileus who was diagnosed with synchronous colon and breast cancer. PRESENTATION OF CASE: A 57year old male patient presented to the Emergency Clinic with abdominal pain, vomiting, constipation and lack of flatulence. The patient was taken to the operating room for emergency surgery with the diagnosis of intestinal obstruction. While still hospitalized, breast ultrasound was performed, revealing a mass lesion in the right breast measuring 2cm. The core biopsy result was suggestive of invasive ductal adenocarcinoma. Right modified radical mastectomy with removal of the level 2 axillary lymph nodes was performed. The result of the histopathological investigation of the right hemicolectomy specimen was reported as moderately differentiated adenocarcinoma, while that of the mastectomy material was invasive ductal adenocarcinoma. DISCUSSION: Synchronous colorectal cancer is recognized as an important clinical entity, its clinical and pathological properties as well as prognosis are still undetermined. A family history of cancer might be a significant factor in synchronous cancers. Many of the theories about the etiology of multiple primary malignant neoplasia suggest the role of genetic, hormonal, environmental and immunological factors as well as iatrogenic causes.Entities:
Keywords: Breast; Case report; Colon; Ileus; Male; Synchronous
Year: 2016 PMID: 27677113 PMCID: PMC5037206 DOI: 10.1016/j.ijscr.2016.09.023
Source DB: PubMed Journal: Int J Surg Case Rep ISSN: 2210-2612
Fig. 1Abdomen plan X-ray.
Fig. 2A contrast-enhanced computed tomography (oral and IV contrast) of the abdomen.
Fig. 3Magnetic resonance imaging of the left breast.
Fig. 4Colonic type malignant invasive glandular structures (Hematoxylin and eosin ×200).
Fig. 5Malignant breast invasive ductal carcinoma glandular structures (hematoxylin and eosin ×200).